Brilliant blue G-250

CAS No. 6104-58-1

Brilliant blue G-250( Brilliant Blue G | BBG | Acid blue 90, Coomassie Brilliant Blue G )

Catalog No. M27320 CAS No. 6104-58-1

Brilliant Blue G is an antagonist of the P2X7 purinergic receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
25MG 29 In Stock
50MG 36 In Stock
100MG 50 In Stock
200MG Get Quote In Stock
500MG 119 In Stock
1G 176 In Stock

Biological Information

  • Product Name
    Brilliant blue G-250
  • Note
    Research use only, not for human use.
  • Brief Description
    Brilliant Blue G is an antagonist of the P2X7 purinergic receptor.
  • Description
    Brilliant Blue G is an antagonist of the P2X7 purinergic receptor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Brilliant Blue G | BBG | Acid blue 90, Coomassie Brilliant Blue G
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    P2X Receptor
  • Recptor
    AChE
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6104-58-1
  • Formula Weight
    854.02
  • Molecular Formula
    C47H48N3NaO7S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 12.5 mg/mL (14.64 mM)
  • SMILES
    [Na+].CCOc1ccc(Nc2ccc(cc2)C(=C2\C=C/C(/C=C2C)=[N+](\CC)Cc2cccc(c2)S([O-])(=O)=O)\c2ccc(cc2C)N(CC)Cc2cccc(c2)S([O-])(=O)=O)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cardoso-Lopes EM, et al. Alkaloids from stems of Esenbeckia leiocarpa Engl. (Rutaceae) as potential treatment for Alzheimer disease. Molecules. 2010 Dec 13;15(12):9205-13.
molnova catalog
related products
  • PPADS tetrasodium

    PPADS tetrasodiuma is a potent P2X receptor antagonist and inhibitor of the inverse mode of Na/Ca2? exchange in guinea pig airway smooth muscle and is neuroprotective against glutamate/NMDA toxicity.PPADS tetrasodiuma inhibits P2X1, P2X-2, P2X-3, and P2X- 5. 5.

  • Opiranserin hydrochl...

    Opiranserin (VVZ-149) hydrochloride is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A), with IC50s of 0.86 and 1.3 μM, respectively. It shows antagonistic activity on rP2X3 (IC50=0.87 μM). It is development as an injectable agent for the treatment of postoperative pain.

  • Minodronic acid

    Minodronic acid(YM-529) is a P2X2/3 receptor antagonist with anticancer activity, directly or indirectly inhibiting the proliferation of cancer cells and inducing apoptosis.